home / stock / sgfef / sgfef news
The European Medicines Agency (EMA) has approved two new production sites of Pfizer (NYSE:PFE)/ BioNTech (NASDAQ:BNTX) COVID-19 vaccine allowing the companies to deliver up to 50 million additional doses in 2021. Both facilities are located in Germany and will manufacture the finished product...
BioNTech (BNTX), the partner of Pfizer (PFE) in COVID-19 vaccine development has enlisted as many as 13 companies in forming a new manufacturing alliance aimed at accelerating the deliveries of its messenger-RNA based COVID-19 shot, the Wall Street Journal reports.BioNTech, which has com...